Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry

• मुख्य लेखकों: Ferenc Takács (लेखक), Lili Kotmayer (लेखक), Ágnes Czeti (लेखक), Gábor Szalóki (लेखक), Tamás László (लेखक), Gábor Mikala (लेखक), Ágnes Márk (लेखक), András Masszi (लेखक), Péter Farkas (लेखक), Márk Plander (लेखक), Júlia Weisinger (लेखक), Judit Demeter (लेखक), Sándor Fekete (लेखक), László Szerafin (लेखक), Beáta Margit Deák (लेखक), Erika Szaleczky (लेखक), Adrienn Sulák (लेखक), Zita Borbényi (लेखक), Gábor Barna (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Ibrutinib is widely known as an effective and well-tolerated therapeutical choice of the chronic lymphocytic leukaemia (CLL). However, acquired resistance may occur during the treatment, causing relapse. Early detection of ibrutinib resistance is an important issue, therefore we aimed to...